Skip to content
Search

Latest Stories

India will be among the top three economies of the world in a couple of decades, says Mukesh Ambani

RELIANCE INDUSTRIES chairman Mukesh Ambani  has said that India should pursue twin goals of becoming an economic and green energy superpower as the country will be among the top three economies of the world in a couple of decades.

While speaking at the convocation event of Gandhinagar-based Pandit Deendayal Upadhyay University, Ambani said that Indian economy  will witness an 'explosive and exponential growth' in the post-Covid era.


"To achieve these twin goals, we need disruptive solutions in renewables, low carbon and carbon recycle technologies. We need breakthroughs in renewable energy sources such as green and blue hydrogen," Ambani, who is also the president of the board of the University said.

Indian prime minister Narendra Modi was the chief guest for the event which was organised via video conferencing.

"The future is very bright for India. This is our ancient nation that has faced many adversities in the past and has emerged stronger each time. This is because resilience is in the very DNA of Indian people and Indian culture," India's richest man said.

"The most important question we face is this-can we produce growing amounts of energy we need to sustain our economies without harming the environment, without failing to fulfill our climate change obligations. We must be prepared to answer these questions with a very confident 'yes'."

Ambani also advised students to continue the process of learning, as a 'constant and never-ending process of exploration, discovery and adventure'.

"A true student never stops the pursuit of knowledge. The world is waiting for you. Step out and take the plunge. Fail, if necessary, but in pursuit of your dream with passion, purpose and persistent effort. Your dreams will indeed come true," he said.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less